Biologics
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced plans to establish a manufacturing facility in Nashvil...
September 10, 2021 | News
This latest fund represents a significant expansion of the principal investment business of RMG, building on the team's 25-plus year history in life scienc...
September 08, 2021 | News
The first CAR-T product independently developed in China and approved as a Category 1 biologics product, and the sixth approved CAR-T product g...
September 07, 2021 | News
FLYSYN is a fms-like tyrosine kinase 3 (FLT3) specific antibody for the treatment of acute myeloid leukemia (AML) patients in complete remission. FLYSYN wa...
September 06, 2021 | News
Thermo Fisher Scientific's clinical sequencing business and AstraZeneca today announced they will co-develop next-generation sequencing (NGS)-based compani...
September 02, 2021 | News
Cryoport and MLC will partner to create synergistic value by leveraging each other's global logistics networks. The partnership will provide integrated, en...
August 26, 2021 | News
The investment will significantly expand Quotient’s drug substance manufacturing capability and will create 80 new jobs over the next three yea...
August 25, 2021 | News
Cytiva, a global life sciences leader, has partnered with Mycenax Biotech Inc, a leading biopharmaceutical CDMO company, to launch Taiwan’s first con...
August 23, 2021 | News
Leveraging the respective business advantages, both parties plan to strengthen cooperation in supplementary medical insurance and health insurance policy, ...
August 23, 2021 | News
Founded in 2015, Standigm has proprietary technology including AI platforms encompassing novel target identification to novel compound design to generate c...
August 20, 2021 | News
Senhwa Biosciences, Inc., a drug development company focused on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, today ann...
August 19, 2021 | News
Taiwan's CDE is an instrumental partner of the Taiwan Food and Drug Administration (TFDA), assisting in drafting regulations and guidance, while ...
August 14, 2021 | News
The Australian biotech sector is actively considering how it can support greater access to ground-breaking therapies for Australians, as RM challenges the ...
August 13, 2021 | News
Frost & Sullivan's recent analysis finds that digital therapeutics (DTx) in the United States are considered legitimate alternatives to tradi...
August 10, 2021 | News
Most Read
Bio Jobs
News